K. Tecen-Yucel Et Al. , "Clinical Pharmacy Practices in Oncology Patients Treated with Tyrosine Kinase Inhibitors," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.1, pp.53-60, 2018
Tecen-Yucel, K. Et Al. 2018. Clinical Pharmacy Practices in Oncology Patients Treated with Tyrosine Kinase Inhibitors. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.1 , 53-60.
Tecen-Yucel, K., EKİNCİOĞLU, A., Kilickap, S., & ERMAN, M., (2018). Clinical Pharmacy Practices in Oncology Patients Treated with Tyrosine Kinase Inhibitors. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.1, 53-60.
Tecen-Yucel, KAMER Et Al. "Clinical Pharmacy Practices in Oncology Patients Treated with Tyrosine Kinase Inhibitors," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.1, 53-60, 2018
Tecen-Yucel, KAMER T. Et Al. "Clinical Pharmacy Practices in Oncology Patients Treated with Tyrosine Kinase Inhibitors." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.1, pp.53-60, 2018
Tecen-Yucel, K. Et Al. (2018) . "Clinical Pharmacy Practices in Oncology Patients Treated with Tyrosine Kinase Inhibitors." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.1, pp.53-60.
@article{article, author={KAMER TECEN YÜCEL Et Al. }, title={Clinical Pharmacy Practices in Oncology Patients Treated with Tyrosine Kinase Inhibitors}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2018, pages={53-60} }